Cargando…
Nitric Oxide (NO) and Duchenne Muscular Dystrophy: NO Way to Go?
The discordance between pre-clinical success and clinical failure of treatment options for Duchenne Muscular Dystrophy (DMD) is significant. The termination of clinical trials investigating the phosphodiesterase inhibitors, sildenafil and tadalafil (which prolong the second messenger molecule of nit...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764682/ https://www.ncbi.nlm.nih.gov/pubmed/33322149 http://dx.doi.org/10.3390/antiox9121268 |